Korean J Intern Med.
2018 Mar;33(2):432-434. 10.3904/kjim.2015.295.
Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea. shimby@catholic.ac.kr
- 2Department of Pathology, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea.
- KMID: 2411555
- DOI: http://doi.org/10.3904/kjim.2015.295
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Postoperative Cure for Metastatic Gastrointestinal Stromal Tumor
- A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib
- C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
- Imatinib-induced DRESS Syndrome in Gastrointestinal Stromal Tumor
- Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
